Why Risk Management Matters
Risk management is the backbone of every medical device quality management system. It is not a standalone activity — it is a process that must be integrated into design, manufacturing, supplier management, post-market surveillance, and every decision that affects patient safety. Yet it remains one of the most frequently cited areas of nonconformity across all regulatory frameworks.
#1
FDA Warning Letter
Citation Category
Citation Category
Top
MDSAP NC Category
Across Jurisdictions
Across Jurisdictions
Top
EU MDR Rejection
Cause (Annex I)
Cause (Annex I)
3x+
Estimated Cost of
Late-Stage Fixes
Late-Stage Fixes
Common Regulatory Nonconformities
- ISO 14971 Clause 3 requires the Risk Management Plan to define scope, responsibilities, review criteria, and verification activities — many plans lack one or more of these mandatory elements
- ISO 14971 Clause 4.3 requires systematic hazard identification for both normal and fault conditions — hazard analyses frequently omit foreseeable misuse scenarios and use-environment hazards
- ISO 14971 Clause 5 requires documented risk acceptability criteria — severity and probability scales are often undefined or inconsistent across product families
- ISO 14971 Clause 7 requires evaluation of overall residual risk — this mandatory step is missing in a significant number of risk management files
- ISO 14971 Clause 9 requires production and post-production information to feed back into the risk management file — complaint data and PMS reports are routinely disconnected
- EU MDR Annex I GSPR 1–9 requires risk reduction as far as possible — risk management files frequently lack documented rationale for residual risk acceptability
- IEC 62304 requires software risk management integrated with ISO 14971 — SOUP risk assessment and software hazard analysis are commonly absent
- IEC 62366-1 requires use error risk analysis linked to ISO 14971 — usability engineering outputs are frequently not traced to the risk management file
Regulatory Landscape
Each regulatory framework imposes specific risk management requirements. Our documentation is built to satisfy all of them simultaneously.
| Framework | Key Risk Management Requirements |
|---|---|
| ISO 14971:2019 | Clauses 3–9 mandate the complete risk management process: plan, hazard identification, risk estimation, risk evaluation, risk control (with priority order per Clause 6.2), residual risk evaluation, risk management review, and production/post-production monitoring. Requires documented risk acceptability criteria and traceability. |
| ISO/TR 24971:2020 | Normative guidance on implementing ISO 14971. Covers benefit-risk analysis methodology, risk management for IVDs, cybersecurity risks, biological hazards, and QMS integration requirements. |
| FDA QMSR(21 CFR 820, as amended 2026) | Incorporates ISO 13485 and ISO 14971 by reference (effective February 2, 2026). Replaces standalone design control language. Risk analysis required within design controls, CAPA, complaint handling, and throughout the QMS. |
| EU MDR 2017/745Annex I (GSPR) | GSPR 1–9 mandate risk management throughout the device lifecycle. Requires risk-benefit analysis per Annex I §1. Annex II requires risk management file in technical documentation. Annex XIV Part B requires PMCF data to feed risk management. |
| MDSAP(5 Jurisdictions) | Chapter 5 covers risk management across all five participating authorities (FDA, Health Canada, TGA, ANVISA, MHLW/PMDA). Risk is a cross-cutting requirement assessed across all seven MDSAP chapters. |
| UK MDR 2002(UKCA) | Schedule 1 Essential Requirements mandate risk-benefit analysis consistent with EU MDR principles. MHRA requires risk management integrated with conformity assessment. |
REGULATORY UPDATE: FDA QMSR (effective February 2, 2026)
The Quality Management System Regulation incorporates ISO 13485 and ISO 14971 by reference, replacing standalone 21 CFR 820 design control language with ISO-aligned requirements for risk-based QMS compliance.
Our Services
RISK MANAGEMENT SYSTEM DEVELOPMENT
- Complete risk management procedure (SOP) harmonized to ISO 14971:2019, FDA QMSR, EU MDR, MDSAP, and UK MDR
- Risk Management Plan templates addressing all mandatory elements per ISO 14971 Clause 3
- Risk acceptability criteria and matrix development per ISO 14971 Clause 5
- Hazard identification methodology aligned to ISO 14971 Clause 4.3 and ISO/TR 24971 Annex C
- QMS integration mapping per ISO 13485 Clause 7.1: design controls, CAPA, complaints, supplier management, production
RISK MANAGEMENT FILE REVIEW & REMEDIATION
- Gap analysis of existing risk management files against ISO 14971:2019 clause-by-clause requirements
- Remediation of FMEA, FTA, and hazard analysis worksheets per ISO 14971 Clauses 4.3, 4.4, and 6
- Overall residual risk assessment per ISO 14971 Clauses 7 and 8
- Benefit-risk analysis documentation meeting EU MDR Annex I GSPR 1–9
- Risk management review facilitation per ISO 14971 Clause 8
RISK-BASED PROCESS INTEGRATION
- Design control risk integration — ensuring inputs, outputs, verification, and validation address identified risks
- CAPA process risk linkage — risk-based prioritization tied to risk reduction effectiveness
- Supplier management risk assessment — risk-based supplier classification and monitoring
- Post-market surveillance risk feedback loops — complaints, vigilance, and PMCF to risk file
- Production risk controls — process risk assessment tied to risk analysis outputs
TRAINING & COMPETENCY DEVELOPMENT
- ISO 14971:2019 comprehensive training — clause-by-clause with practical application
- Cross-functional risk management training for R&D, manufacturing, quality, regulatory, clinical
- FMEA, FTA, and hazard analysis workshops using your actual products and processes
- Regulatory-specific training: FDA QMSR, EU MDR Annex I, MDSAP Chapter 5, UKCA
Complete Document Package — 14 Deliverables
Every engagement produces audit-ready documentation satisfying requirements across all applicable regulatory markets.
| Doc Number | Title | Description |
|---|---|---|
| SOP-RM-001 | Risk Management Procedure | Master procedure harmonized to ISO 14971:2019, FDA QMSR, EU MDR Annex I, MDSAP Ch.5, UK MDR |
| FRM-RM-001 | Risk Management Plan Template | All mandatory plan elements per ISO 14971 Clause 3 with regulatory cross-reference matrix |
| FRM-RM-002 | Hazard Identification Worksheet | Structured per ISO 14971 Clause 4.3 and ISO/TR 24971 Annex C hazard categories |
| FRM-RM-003A | Product Risk Assessment (dFMEA) | Design FMEA per ISO 14971 Clauses 4.3–5 for device design, software, usability hazards |
| FRM-RM-003B | Process Risk Assessment (pFMEA) | Process FMEA per ISO 14971 & ISO 13485 Cl.7.5 for manufacturing and production hazards |
| FRM-RM-004 | Fault Tree Analysis Template | Top-down FTA per ISO 14971 Clause 4.4 for systematic root-cause hazard analysis |
| FRM-RM-005 | Risk Evaluation & Acceptability Matrix | Customizable matrix per ISO 14971 Clause 5 with defined acceptability regions |
| FRM-RM-006 | Risk Control Verification Form | Verification per ISO 14971 Clause 6.3–6.5 for implementation and effectiveness |
| FRM-RM-007 | Residual Risk Evaluation Form | Individual and overall residual risk per ISO 14971 Clauses 7–8 with EU MDR benefit-risk section |
| FRM-RM-008 | Risk Management Review Checklist | Complete review per ISO 14971 Clause 8 verifying all mandatory process steps |
| FRM-RM-009 | Risk Management Report Template | Summary report per ISO 14971 Clause 8 with product/process RA statistics and regulatory status |
| FRM-RM-010 | Post-Production Monitoring Log | Tracking per ISO 14971 Clause 9 for production/post-production information feedback |
| FRM-RM-011 | Product Realization Risk Assessment | Risk integration at each realization phase per ISO 13485 Cl.7.1 and FDA QMSR §820.30 |
| REF-RM-001 | Regulatory Cross-Reference Matrix | Clause-by-clause mapping: ISO 14971 ↔ FDA QMSR ↔ EU MDR ↔ MDSAP (all 5) ↔ UK MDR |
Engagement Models
Document Package Only
Complete Risk Management Document Package (all 14 templates and forms) for independent implementation. Ideal for organizations with experienced RM staff.
Gap Assessment + Remediation
Clause-by-clause review of existing risk management files, gap identification, prioritized remediation roadmap, and hands-on documentation fixes.
Full System Development
End-to-end risk management system build-out from procedure development through implementation. Includes all documentation, training, and QMS integration mapping.
Training & Workshops
Customized programs from half-day sessions to multi-day workshops. ISO 14971, FMEA/FTA techniques, and auditor preparation. On-site or virtual.
Why SA Quality Solutions
- Deep regulatory expertise across ISO 14971, FDA QMSR, EU MDR, MDSAP (all 5 jurisdictions), and UKCA — every deliverable built directly from the standards and regulations.
- 20+ years in medical device quality and regulatory affairs spanning R&D, manufacturing, notified body operations, and regulatory consulting.
- Certified across ISO 13485, MDSAP, EU MDR/MDD, and EXCiPact — one resource covering your entire regulatory footprint.
- Process-based methodology — your risk management system will satisfy the intent of ISO 14971, not just the paperwork requirements.
- Direct experience with FDA, Health Canada, TGA, ANVISA, and MHLW/PMDA — documentation built to meet each jurisdiction’s specific requirements under MDSAP.
- Implementation-focused — we develop the procedures, build the templates, create the regulatory cross-references, and train your team to maintain the system independently.
Ready to Strengthen Your Risk Management System?
Contact us for a complimentary initial assessment of your current risk management documentation.
Schedule a Consultation